USD 0.51
(0.0%)
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2023 | - USD | 0.0% |
2022 | - USD | 0.0% |
2021 | - USD | 0.0% |
2020 | - USD | -100.0% |
2019 | 3.38 Million USD | -98.25% |
2018 | 193.42 Million USD | -1.97% |
2017 | 197.3 Million USD | 725.17% |
2016 | 23.91 Million USD | 8.96% |
2015 | 21.94 Million USD | -4.88% |
2014 | 23.07 Million USD | 0.0% |
2013 | - USD | 0.0% |
2012 | - USD | 0.0% |
2011 | - USD | 0.0% |
2010 | - USD | 0.0% |
2009 | - USD | 0.0% |
2008 | - USD | -100.0% |
2007 | 1.65 Million USD | -43.13% |
2006 | 2.91 Million USD | 0.0% |
2004 | - USD | 0.0% |
2003 | - USD | 0.0% |
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2024 Q2 | - USD | 0.0% |
2024 Q1 | - USD | 0.0% |
2023 Q3 | - USD | 0.0% |
2023 Q1 | - USD | 0.0% |
2023 Q4 | - USD | 0.0% |
2023 FY | - USD | 0.0% |
2023 Q2 | - USD | 0.0% |
2022 Q2 | - USD | 0.0% |
2022 Q1 | - USD | 0.0% |
2022 Q4 | - USD | 0.0% |
2022 Q3 | - USD | 0.0% |
2022 FY | - USD | 0.0% |
2021 Q2 | - USD | 0.0% |
2021 Q3 | - USD | 0.0% |
2021 Q4 | - USD | 0.0% |
2021 FY | - USD | 0.0% |
2021 Q1 | - USD | 0.0% |
2020 Q3 | 157.88 Million USD | 0.14% |
2020 Q2 | 157.65 Million USD | -30.68% |
2020 FY | - USD | -100.0% |
2020 Q1 | 227.42 Million USD | 19.18% |
2020 Q4 | - USD | -100.0% |
2019 Q4 | 190.82 Million USD | 4.37% |
2019 Q3 | 182.82 Million USD | -1.9% |
2019 Q2 | 186.35 Million USD | -1.86% |
2019 FY | 3.38 Million USD | -98.25% |
2019 Q1 | 189.89 Million USD | -1.83% |
2018 Q1 | 196.33 Million USD | -0.49% |
2018 FY | 193.42 Million USD | -1.97% |
2018 Q4 | 193.42 Million USD | -0.5% |
2018 Q3 | 194.39 Million USD | -0.5% |
2018 Q2 | 195.36 Million USD | -0.49% |
2017 Q4 | 197.3 Million USD | -0.26% |
2017 Q3 | 197.81 Million USD | 768.75% |
2017 Q1 | 23.34 Million USD | -2.38% |
2017 FY | 197.3 Million USD | 725.17% |
2017 Q2 | 22.77 Million USD | -2.45% |
2016 Q4 | 23.91 Million USD | -1.37% |
2016 Q1 | 21.68 Million USD | -1.18% |
2016 FY | 23.91 Million USD | 8.96% |
2016 Q2 | 36.01 Million USD | 66.07% |
2016 Q3 | 24.24 Million USD | -32.68% |
2015 FY | 21.94 Million USD | -4.88% |
2015 Q1 | 22.8 Million USD | -1.14% |
2015 Q4 | 21.94 Million USD | -1.52% |
2015 Q3 | 22.28 Million USD | -1.16% |
2015 Q2 | 22.54 Million USD | -1.15% |
2014 Q4 | 23.07 Million USD | 35.12% |
2014 Q2 | 17.18 Million USD | 83.22% |
2014 Q1 | 9.38 Million USD | 0.0% |
2014 FY | 23.07 Million USD | 0.0% |
2014 Q3 | 17.07 Million USD | -0.65% |
2013 FY | - USD | 0.0% |
2013 Q1 | - USD | 0.0% |
2013 Q2 | - USD | 0.0% |
2013 Q3 | - USD | 0.0% |
2013 Q4 | - USD | 0.0% |
2012 Q1 | - USD | 0.0% |
2012 FY | - USD | 0.0% |
2012 Q3 | - USD | 0.0% |
2012 Q2 | - USD | 0.0% |
2012 Q4 | - USD | 0.0% |
2011 FY | - USD | 0.0% |
2011 Q4 | - USD | 0.0% |
2011 Q2 | - USD | 0.0% |
2011 Q1 | - USD | 0.0% |
2011 Q3 | - USD | 0.0% |
2010 Q4 | - USD | 0.0% |
2010 Q2 | - USD | 0.0% |
2010 Q3 | - USD | 0.0% |
2010 Q1 | - USD | 0.0% |
2010 FY | - USD | 0.0% |
2009 Q1 | - USD | 0.0% |
2009 Q3 | - USD | 0.0% |
2009 Q2 | - USD | 0.0% |
2009 FY | - USD | 0.0% |
2009 Q4 | - USD | 0.0% |
2008 Q2 | 25 Thousand USD | -98.19% |
2008 Q4 | - USD | 0.0% |
2008 Q1 | 1.38 Million USD | -16.52% |
2008 FY | - USD | -100.0% |
2008 Q3 | - USD | -100.0% |
2007 Q4 | 1.65 Million USD | 0.0% |
2007 Q2 | 2.2 Million USD | 0.0% |
2007 FY | 1.65 Million USD | -43.13% |
2006 FY | 2.91 Million USD | 0.0% |
2006 Q4 | 2.91 Million USD | 0.0% |
2004 FY | - USD | 0.0% |
2003 FY | - USD | 0.0% |
Name | Long Term Debt | Long Term Debt Difference |
---|---|---|
CareCloud, Inc. | 10.03 Million USD | 100.0% |
Augmedix, Inc. | 15.3 Million USD | 100.0% |
BrightSpring Health Services, Inc. Common Stock | 3.33 Billion USD | 100.0% |
CareCloud, Inc. | 10.03 Million USD | 100.0% |
HealthEquity, Inc. | 874.97 Million USD | 100.0% |
iCoreConnect Inc. | 1.42 Million USD | 100.0% |
Inovalon Holdings, Inc. | 877.57 Million USD | 100.0% |
Nutex Health, Inc. | 26.31 Million USD | 100.0% |
Omnicell, Inc. | 569.66 Million USD | 100.0% |
OneMedNet Corporation | 465.02 Thousand USD | 100.0% |
Progyny, Inc. | 17.24 Million USD | 100.0% |
Renalytix Plc | 4.33 Million USD | 100.0% |
Schrödinger, Inc. | 111.01 Million USD | 100.0% |
Simulations Plus, Inc. | 531 Thousand USD | 100.0% |
SOPHiA GENETICS SA | 15.67 Million USD | 100.0% |
Streamline Health Solutions, Inc. | 9.06 Million USD | 100.0% |
Ontrak, Inc. | 1.46 Million USD | 100.0% |
GE HealthCare Technologies Inc. | 8.74 Billion USD | 100.0% |
Sharecare, Inc. | 519 Thousand USD | 100.0% |
Aclarion, Inc. | - USD | NaN% |
CareMax, Inc. | 21.44 Million USD | 100.0% |
Bullfrog AI Holdings, Inc. Common Stock | - USD | NaN% |
Forian Inc. | 22.99 Million USD | 100.0% |
Bullfrog AI Holdings, Inc. Warrants | - USD | NaN% |
GeneDx Holdings Corp. | 52.68 Million USD | 100.0% |
SCWorx Corp. | 90.35 Thousand USD | 100.0% |
Minerva Surgical, Inc. | 37.44 Million USD | 100.0% |
Definitive Healthcare Corp. | 242.56 Million USD | 100.0% |
10x Genomics, Inc. | 83.84 Million USD | 100.0% |
Zhongchao Inc. | 571.86 Thousand USD | 100.0% |
Accolade, Inc. | 208.48 Million USD | 100.0% |
MSP Recovery, Inc. | 678.98 Million USD | 100.0% |
R1 RCM Inc. | 1.64 Billion USD | 100.0% |
Spok Holdings, Inc. | 6.9 Million USD | 100.0% |
Privia Health Group, Inc. | 5.24 Million USD | 100.0% |
EUDA Health Holdings Limited | 75.11 Thousand USD | 100.0% |
TruBridge, Inc. | 198.34 Million USD | 100.0% |
BrightSpring Health Services, Inc. Tangible Equity Unit | 3.33 Billion USD | 100.0% |
Sharecare, Inc. | 519 Thousand USD | 100.0% |
Health Catalyst, Inc. | 228.03 Million USD | 100.0% |
GoodRx Holdings, Inc. | 647.7 Million USD | 100.0% |
Premier, Inc. | 11.17 Million USD | 100.0% |
HealthStream, Inc. | 20.24 Million USD | 100.0% |
Certara, Inc. | 288.21 Million USD | 100.0% |
GeneDx Holdings Corp. | 52.68 Million USD | 100.0% |
Ontrak, Inc. | 1.46 Million USD | 100.0% |
SHL Telemedicine Ltd. | 10.43 Million USD | 100.0% |
CareCloud, Inc. | 10.03 Million USD | 100.0% |
EUDA Health Holdings Limited | 75.11 Thousand USD | 100.0% |
HeartBeam, Inc. | - USD | NaN% |
Mangoceuticals, Inc. | 64.96 Thousand USD | 100.0% |
CareMax, Inc. | 21.44 Million USD | 100.0% |
Healthcare Triangle, Inc. | 888 Thousand USD | 100.0% |
National Research Corporation | 29.47 Million USD | 100.0% |
Aclarion, Inc. | - USD | NaN% |
OptimizeRx Corporation | 34.23 Million USD | 100.0% |